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Summary. Background: Intrachromosomal homologous
recombination between inverted repeats on the X chromosome
account for about half of severe hemophilia A cases. Repeats in
F8 intron 1 and intron 22 can recombine with homologous
inverted repeats located about 200 kb upstream and 500 kb
downstream of F8, respectively, resulting in partial sequence
inversion of the F8 open reading frame and, subsequently, no
functional proteinproduction. Objectives: In thepresent study,
we characterize a third novel homologous recombination at
Xq28 consistent with absence of F8 transcription that we
previously reported for the aﬀected chromosome of the index
patient as well as his mother and sister. Results: The rear-
rangement occurs between a repeat inF8 intron 1 (Int1R-1) and
an inverted identical repeat (Int1R-2d) in intron 2 of a
duplicated copy of IKBKG located about 386 kb upstream of
F8. The rearrangement was conﬁrmed by Southern blot and
inverse PCR and results in failure of PCR ampliﬁcation across
Int1R-1. Conclusion: We developed a PCR-based diagnostic
method that canbeused to screen for this genetic rearrangement
in cases of severe hemophilia A for which mutations cannot be
identiﬁed.
Keywords: duplication, F8, genomic rearrangement, hemo-
philia A, homologous recombination, IKBKG.
Introduction
The Xq28 locus appears to be prone to several types of
rearrangements [1]. The presence of several long, almost
identical, homologous sequence repeats at Xq28 accounts for
the high frequency at which these rearrangements occur. Two
such rearrangements have been previously described that
disrupt F8 and lead to severe hemophilia A [2–4]. These
inversions are as a result of homologous recombination
between identical inverted repeats, one being in F8 and another
one on the same DNA strand.
The ﬁrst rearrangement was described by Lakich et al. [2]
who showed that intrachromosomal homologous recombina-
tion between a 9.1-kb repeat inF8 intron 22 (Int22h) and one of
at least two copies of identical inverted repeats 500 kb
towards the telomere, results in inversion of the intervening
sequence (i.e. the sequence between the two repeats was
inverted). This inversion hotspot accounts for about half of all
severe hemophilia A cases (20–25% of all hemophilia A cases).
The second rearrangement was ﬁrst described by Brinke
et al.[3] and was shown by Bagnall et al.[4] to be a recurrent
mutational hotspot. The second rearrangement accounts for 1–
5% of all hemophilia A cases [5]. The mechanism of the second
rearrangement is similar to that of the intron 22 inversion,
however, a different repeat in intron 1 (Int1h-1) is involved in
the homologous recombination with an inverted repeat
approximately 200 kb upstream of F8. Both known inversions,
Int1 and Int22, cause the splitting ofF8 into two reading frames
in opposite directions.
The discoveries of these two inversion hotspots considerably
decreased the number of hemophilia A patients without a
deﬁned genetic basis for the disease. Nevertheless, in a minority
of cases, none of the known genetic variants of F8, including
point mutations, indels, large duplications or either of the ﬁrst
two reported inversions, could be diagnosed [6,7]. Thus, one or
more as yet uncharacterized F8 disruptions must be causal for
these rare cases. Accordingly, we previously reported absence
of F8 expression from an allele present in both index patients
and heterozygous female family members [8]. In this study we
describe a novelmolecularmechanism leading to the absence of
F8mRNA transcript for the patient in this family. We found a
novel third homologous recombinant rearrangement induced
by inverted repeats at Xq28. This rearrangement arises through
sequential events. First, there is a duplication of an approxi-
mately 94-kb region at Xq28 including the genes IKBKG
(inhibitor of kappa light polypeptide gene enhancer in B-cells,
kinase gamma; NEMO), CTAG1B (cancer/testis antigen 1B)
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and their neighboring pseudo genes. Second, there is a
rearrangement between a repeat within F8 intron 1, designated
here as Int1R-1, and the inverted copy of the same repeat
(Int1R-2d) nested within the duplicated copy of IKBKG intron
2, resulting in inversion of intervening sequence. Based on the
successful analysis and characterization of this rearrangement,
we have developed a simple, rapid PCR method to detect this
defect in severe hemophilia A patients and their carrier relatives
for whom none of the formerly known genetic anomalies can
be diagnosed.
Materials and methods
Patient profile
The index patient is a male hemophilia A patient with a severe
phenotype (< 1 IU dL)1 factor [F]VIII activity) who suffers
from no other known health problems as previously reported
[8]. No inhibitors have been detected. Multiplex ligation-
dependent probe ampliﬁcation (MLPA) analysis showed a
normal allele copy number for F8. No F8 mRNA transcript
was detectable in his total blood RNA [8]. The family gave
written informed consent to participate in the study in
accordance with the Declaration of Helsinki. The Ethic
Committee of the University of Bonn approved the study
(approval 183/07).
Long-range PCR
Long-range (LR)-PCR was performed on genomic DNA for
the complete genomic region of F8 by ampliﬁcation of 28
overlapping fragments using the Expand Long Template PCR
System (Roche Diagnostics GmbH, Penzberg, Germany)
according to the manufacturers instructions. Thermal cycling
conditions were as follows: 2-min initial denaturation at 92 C,
10 cycles at 92 C for 10 s, 55–65 C (depending on the primers
used) for 30 s and 68 C for 1 min per kb (depending on the
size of the amplicons), 20 cycles at 92 C for 10 s, 55–65 C for
30 s and 68 C for 1 min per kb + 20 s per cycle, followed by
7 min at 68 C. PCR products were analyzed on 1% (w/v)
agarose gels. Primers details are in Table S1.
Identification of breakpoint location
To further narrow down the location of the breakpoint, various
primer pairs were designed ﬂanking the non-ampliﬁable region.
The non-ampliﬁable region of the LR-PCR (Fig. 1; region B1)
was subdivided into ﬁve overlapping fragments of approxi-
mately 1–1.5 kb. PCR conditions were as follows: 15-min
initial activation at 95 C, followed by 35 cycles at 95 C for
30 s, 62 C for 30 s and 72 C for 2 min using HOT
FIREPolDNA Polymerase (Solis BioDyne, Tartu, Estonia).
Primers are listed in Table S1.
Detection of repetitive elements
The sequence ﬂanking the minimal non-ampliﬁable breakpoint
was analyzed with RepeatMasker (http://www.repeatmas-
ker.org/) to detect features of repetitive elements that might
be associated with the breakpoint. Sequence homology
between this region and the whole human genome was
analyzed using the basic human BLAT search tool (http://
genome.ucsc.edu/cgi-bin/hgBlat?command=start). A dot plot
matrix analysis of the F8 genomic region compared with a
concatenated 1-Mb sequence (500 kb upstream and down-
stream of the Int1R-1 in F8 intron 1) at Xq28 was performed
using Geneious software (http://www.geneious.com/).
Southern blot analysis
Restriction enzymes BamHI, HincII, BstApI, EcoRI and NdeI
(100 units each; NewEngland Biolabs, Frankfurt, Germany) in
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B1
1505 bp
P C P C P C P C P C
962 bp 942 bp 962 bp 1501 bp
(5251 bp)
Int1h-1 2-6 Cen. C
LR-
PCR: B1
region
5 kb
1 kb
lnt1h-1lnt1R-1
1042 bp1185 bp687 bp
P
A
B
Fig. 1. Location of the breakpoint in the F8 intron 1. (A) The relative location of Int1h-1 and the identiﬁed Int1R-1 repeat in the non-ampliﬁable long-
range (LR)-PCR are shown; a schematic presentation of F8 locus from exon 1 to exon 6 is shown at the upper part and the PCR ampliﬁcation of the region
B1 is shown in the box at the upper right. (B) Detailed localization of the breakpoint using overlapping short-range PCRs (C, control non-hemophilic
DNA; P, patient).
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combination with the appropriate enzyme buffers were used in
separate reactions for cleavage of 10 lg genomic DNA from
the patient, his mother and several non-hemophilic control
patients. A Southern blot probe of 502 bp (chrX:153,891,795–
153,891,293; hg18) that recognizes a region upstream of the
Int1R-1 repeat was ampliﬁed by standard PCR conditions for
healthy control DNA using primers described in Table S1. The
Southern blot and detection was done according to standard
protocols (detail protocols of the southern blot can be obtained
directly from authors).
Inverse PCR amplification and analysis
Brieﬂy genomicDNAwas digestedwithBamHI (NewEngland
Biolabs). After puriﬁcation, digested DNA was ligated using
T4 DNA Ligase (Invitrogen, Life Technologies, Darmstadt,
Germany). The puriﬁed ligated circular products were used as
templates for the LR-PCR reaction using the Expand long
template PCR System (Roche Diagnostics). Primers used for
ampliﬁcation are listed in Table S1. The puriﬁed product was
cloned into the pCR-XL-TOPO and transformed into One-
Shot TOP10 chemically competent Escherichia coli (Invitro-
gen) according to the manufacturers instructions. Individual
colonies were isolated and the entire insert was sequenced using
a primer walking strategy (primer sequences are available on
request). Sequences were assembled and analyzed using
Geneious Pro (Biomatters Ltd, Auckland, New Zealand).
Generated contigs were annotated using BLAT against
assembly Build: hg18, NCBI36 (detail protocols of the inverse
PCR can be obtained directly from authors).
Comparative genomic hybridization array
Next, 2 lg of DNA from the index patient and standard
control male DNA (Promega, Mannheim, Germany) was
labeled with dUTP-coupled cyanine Cy3 and Cy5, respectively.
Both samples were co-hybridized on a NimbleGen Human
comparative genomic hybridization (CGH) 385K chromosome
X Tiling Array (Build: hg18, NCBI36). Data were analyzed
and results were visualized using SignalMap software (Roche,
NimbleGen, Penzberg, Germany).
Results
LR-PCR reveals a breakpoint in the patients F8
LR-PCR was performed to determine the integrity of F8 locus
by amplifying 28 overlapping fragments (Fig. S1). Inability to
amplify a 5.25-kb fragment from F8 intron 1 from the index
patient indicated the presence of a genomic breakpoint in this
region (Fig. 1A). Mapping PCRs using ﬁve different primer
pairs were accordingly designed to further narrow the borders
of the non-ampliﬁable region (Table S1). Using this approach,
the extent of the non-ampliﬁable region was further localized to
a 942-bp region (Fig. 1B). This localized the position of the
putative break caused by a rearrangement in intron 1 to about
1 kb upstream of Int1h-1 (Int1h-1 on chrX: 153,887,576–
153,888,616; hg18).
Sequence analysis near the breakpoint identified the presence
of inverted repeats
As both previously reported inversions in F8 are caused by
intrachromosomal recombination between highly homologous
inverted repeats, we hypothesized that, in this case, a recom-
bination between homologous inverted sequencesmight also be
the cause of the breakpoint. This prompted us to perform a
search of the breakpoint sequence region using dot plot matrix
analysis (Fig. 2A). Analysis of the entire 5.25-kb intronic
sequences ﬂanking the breakpoint (Fig. 1, B1 region LR-
PCRs) revealed the presence of a 687-bp sequence with 98.9%
homology to a sequence at Xq28, but in inverted orientation,
Int1R-1 (chrX: 153,889,754–153,890,442; hg18) and Int1R-2
(chrX: 153,433,817–153,434,506; hg18), respectively
(Fig. 2B,C). This approach indicated a possible homologous
recombination between the identiﬁed repeat in F8 intron 1 and
the highly homologous inverted repeat in intron 2 of IKBKG.
Southern blotting verified the presence of a rearrangement in
the patient and his mother
The predicted novel DNA rearrangement should result in
changes in length of restriction fragments surrounding the
breakpoint. To detect such changes, we used several restric-
tion enzymes whose cleavage sites lie outside of and within
the region of homology. The probe was designed to bind to a
sequence upstream of the non-ampliﬁable region, in a non-
repetitive unique sequence outside the Int1R-1 homologous
region (Fig S2). As expected, use of BstApI, an enzyme
cutting within the Int1R-1 homology region, did not reveal
the postulated rearrangement in the patient and his mother
(data not shown). However by digesting with BamHI, EcoRI,
HincII or NdeI, enzymes whose cutting sites lie outside the
inverted repeat regions (Int1R-1), altered band patterns were
detected in the patient and his carrier mother compared with
the healthy male and female controls. The aberrant band
sizes from the patient sample is consistent with a rearrange-
ment by which the F8 sequence is fused to a sequence in
IKBKG with the breakpoints in the Int1R-1 repeat (as
proved by the inverse PCR analysis in the next section
[Fig. S2]).
Inverse PCR identified the breakpoint junction F8-IKBKG
In order to amplify a DNA fragment containing both
breakpoint junctions associated with the rearrangement, an
inverse PCR approach was used. Primers were designed to
allow inverse PCR ampliﬁcation of regions upstream and
downstream of the F8:Int1R-1 repeat (Fig. 3A). Aberrant
upstream and downstream PCR products were generated from
the patients DNA that were absent in healthy individuals. The
DNA from the mother and sister were heterozygous for both
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Fig. 2. Homology analysis to identify identical repeats within 1 Mb; 500 kb upstream and 500 kb downstream of the breakpoint. (A) Dot plot of 1-Mb
region containing the B1 region at the center vs. F8 locus. The identical repeats, Int22h and Int1h, known to be involved in inversions in F8 and the newly
identiﬁed Int1R, are labeled. The horizontal red bar at the top left of the ﬁgure represents the duplicated 94.4-kb region in the index patient. (B) Dot plot of
IKBKG vs. the F8 B1 region; The Int1h-1 and Int1R repeats are labeled in red and green, respectively. Inverted repeats in dot plot are colored purple and
direct repeats are blue. The word size and the tile size used for the dot plot are 50 and 2000, respectively; Geneious software was used for the analysis. (C)
Alignment of the Int1R-1 in F8 to the Int1R-2 in IKBKG; the pink highlighted sequence represent the consensus sequence; the aligned sequences
correspond to F8: chrX: 153,889,755–153,890,460 and IKBKG: chrX: 153,433,810–153,434,496; hg18.
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junction products (Fig. 3B,C). Subsequently, the inserts were
sequenced using a DNA walking strategy after being cloned
into the pCR-XL-TOPO vector. Sequencing revealed that the
sequence upstream from F8 intron 1 was joined to intron 2 of
IKBKG (Fig. 3B). The sequence downstream of F8 intron 1
was joined to a sequence in the same IKBKG region (Fig. 3C),
about 65 kb away from the region joined to the upstream
breakpoint (Fig. S3); however, a sequence comprising several
repetitive elements, with a high homology to a region in intron
2 of FUNDC2 (chrX: 153,919,264–153,918,534; hg18), was
inserted between the sequence downstream of F8 intron 1
repeat (Int1R-1) and the duplicated sequences in the IKBKG
region (Fig. 3C). We have also veriﬁed using LR-PCR the
integrity of the original FUNDC2 locus (data not shown).
Multiplex PCR detects the rearrangement
In order to provide a straightforward diagnostic test for the
novel F8-IKBKG inversion rearrangement in severe hemophilia
A cases or carrier females, we established a simple multiplex
short range PCR (Fig. 4). Primers that bind to the ﬂanking
regions of the rearrangement junctions would not be expected
to amplify products from theWT allele. Also, primers ﬂanking
the Int1R-1 repeat in WT F8 intron 1 will yield an ampliﬁed
product for both a homozygous WT individual as well as for
the patients heterozygousmother and sister. For these primers,
no ampliﬁcation should take place in the patient. Based on this
strategy, we established a multiplex PCR with three primers:
two of them, 3F and 4R, can amplify the WT F8:Int1R-1,
whereas 2R and 4R together are required for amplifying the
junction corresponding to this region on the recombined
mutant allele (Fig. 4).
Using this established PCR systemwe screened an additional
40 patients with no detectable mutation in the F8 cDNA;
however, no similar rearranged allele was detected. Addition-
ally such a rearrangement could be present in a heterozygous
state in females with the consequence of a reduction in FVIII
activity; therefore, we screened 50 females with decreased
FVIII activity (equally with no detectable mutations in F8
cDNA) without ﬁnding any additional mutant allele. There-
fore, it is most likely that such a complex mutation is not
frequent.
Exclusion of disruption of IKBKG by PCR and detection of a
94-kb duplicated region containing IKBKG
The gene IKBKG has been mapped to a position 386 kb
proximal to F8 locus. IKBKG encodes for the regulatory
subunit of the inhibitor of the kappaB kinase (IKK) complex
required for the activation of the NF-jB pathway. Because of
the essential role of this protein and the fact that rearrange-
ments in IKBKG that lead to a disrupted gene (equivalent to
null mutations) are lethal in both mice and humanmale fetuses
[9,10], the integrity of this locus was conﬁrmed by LR-PCR,
where we were able to amplify the genomic region involved in
the rearrangement in the patient. We obtained an ampliﬁable
product across the Int1R-2 repeat in intron 2 of IKBKG (data
not shown). Therefore, we postulated that the homologous
recombination between inverted repeat copies of Int1R
occurred between the F8 copy and a third repeat outside the
IKBKG. However, as a BLAT search revealed only two copies
of the Int1R repeat, we assumed that an independent
duplication event is probably responsible for the creation of a
third Int1R repeat (designated here as Int1R-2d) in the index
patient genome. To prove this, we screened for duplications on
the patients X chromosome using a CGH array. Indeed, a
duplication of approximately 94.4 kb on the X chromosome
was detected; the duplicated region extends from Int1R-2 in the
IKBKG gene to the IKBKGP (Fig. S3). Further analysis of the
duplicated sequence borders revealed a rich occurrence of
several repeats mainly of the ERV family of repeats that could
have facilitated the generation of the duplication; however, no
clear motives occurred at the borders of the duplicated regions
or the proposed insertion site (Fig. S4).
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Fig. 4. Multiplex PCR identifying the rearrangement. (A) PCR picture: the upper and lower bands correspond to the mutant and normal products,
respectively (P, patient; M, mother; S, sister; C, normal control). (B) Schematic diagram showing the relative positions of the primers 4R-3F and 4R-2R on
both the wild-type and mutant chromosomes, respectively.
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Notably this 94.4-kb duplication appears to be non frequent
as the UCSC track of copy number variations did not reveal
any case with similar duplication with the same borders;
however, two independent studies reported single cases of
duplication involving the Int1R-2: the ﬁrst study by Shaikh
et al. reported a single 1038-kb duplication in an African
descendent (among 2026 multi-ethnic healthy subjects) (chrX:
152,532,027–153,570,321; hg18); whereas Conrad et al.
reported a single 5.79-kb duplication in a Caucasian female
(among 450 individuals) (variation number 74086 (chrX:
153,431,010–153,436,807; hg18)) [11,12]. This shows that
duplications in this region are indeed rare events but cannot
be completely ignored.
Based on the inverse PCR sequences of the downstream
breakpoint it appears that the 5¢ end of the 94.4-kb duplicated
region (before the inversion) is connected to a repeat sequence
with a high homology to a repetitive sequence in intron 2 of
FUNDC2, than followed by a region between CTAG1 and
IKBKG. As the later regions are normally found duplicated,
this gives two possibilities for the position of the insertion: the
ﬁrst between CTAG1B and IKBKG, with the second between
CTAG1A and IKBKGP. The ﬁrst possibility will lead to an
insertion generating Int1R-2d in the same orientation as the
Int1R-1 and thus incompatible with an inversion. Therefore the
second insertion position is more likely (Fig. 5).
Discussion
The majority of hemophilia A cases can be explained by
speciﬁc defects in F8, but in a minority of cases (2%) no genetic
F8 variant can be identiﬁed [6,7]. In such cases, after excluding
large tandem duplications [13,14] and the two previously
reported intron 1 and intron 22 inversions [2,4], or mutations in
introns [15], more complex rearrangements that evade standard
PCR screening strategies need to be considered. For F8, both
unequal homologous recombination between Alu-derived
sequences [16,17] and non-homologous recombination have
been reported to be responsible for deletions [18]. Several
insertions associated with deletions have also been previously
described [19–21].
The IKBKG locus at Xq28 is complex and contains an
inverted segmental duplication of approximately 35.4 kb that
includes a non-functional IKBKGP extending from exons 3 to
10 and a complete duplication of the CTAG1 gene (Fig. S3).
Mutations in IKBKG lead to Incontinentia Pigmenti (IP), a
dominant neuroectodermal disorder where null mutations are
lethal in male fetuses [9]. Inverted orientations and the high
homology of the segmental duplications at this locus are prone
to rearrangements such as inversion and copy number varia-
tion [1,22]. In addition, the high frequency of micro/macro
homologies and repetitive sequences at this locus predispose to
pathological genomic rearrangements [23]. However, none of
the previously characterized rearrangements are outside the
IKBKG locus and the associated inverted segmental duplica-
tion, in contrast to the IKBKG-F8 rearrangement described
here. For approximately 27% of IP patients no genetic defects
could be identiﬁed [24]. Therefore, based on the IKBKG-F8
rearrangement we describe here, it is questionable if a
reciprocal phenomenon for which a homologous recombina-
tion with a duplicated F8 intron 1 would lead to the breakage
of IKBKG. Such a rearrangement does not lead to gain or loss
of DNA or change in IKBKGDNA copy numbers and would
have escaped the traditional screening methods in the IKBKG,
which is based on short-range PCR ampliﬁcation of the coding
sequence [24]. To detect all rearrangements in the IKBKG
including inversions a long-range PCR approach should be
implemented. Also, a third possibility of recombination
between the non-duplicated Int1R-1 and Int1R-2 repeats
Step 1-Duplications Duplicated repeat sequencehomolog to FUNDC2
Duplicated repeat sequence
homolog to FUNDC2
Duplicated sequence from the IKBKG region
Duplicated sequence from the IKBKG region
Insertions of
duplicated
regions
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between int1R-2d and Int1R-1
leading to Inversion
Step 2-
Step 3-
Possible inverted region
Cen.
Cen. Tel.
Tel.
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IKBKG
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G6PD
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CTAG1A
CTAG1B
CTAG1B
CTAG2
CTAG1B
CTAG1B CTAG1A
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Fig. 5. Proposed mechanism of the rearrangement. Three steps are schematically presented, the ﬁrst is the duplication, the second is the insertion of the
duplication, and the third is the intrachromosomal homologous recombination. Part of F8 including exons 1–6 and the IKBKG region are shown; all
annotations and labeling are as in supplementary Fig. S3.
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exists; although lethal in males, it would lead in females to two
consequences: an IP phenotype and a hemophilia A carrier
status with considerable reduction in FVIII activity.
The rearrangement event that we report here is the result of
two events (Fig. 5). The ﬁrst is the duplication of a large 94-kb
region that extends from the functional IKBKG to IKBKGP.
The duplicated region contains the Int1R repeat at one end
(designated Int1R-2d) and appears to be inserted in the
telomeric 35.4-kb segmental duplication (Fig. 5). This rear-
rangement leads to the second event wherein an intra-
chromosomal homologous recombination occurs between
F8:Int1R-1 and Int1R-2d in the duplicated IKBKG gene. As
a result, F8 is split in intron 1 into two oppositely oriented
fragments for which no functional mRNA is transcribed [8].
On the other hand, the essential IKBKG gene is still intact and
transcribed, as the homologous recombination involves the
duplicated copy and not the endogenous IKBKG or IKBKGP.
This explains the absence of additional clinical symptoms in the
hemophilia A phenotype for this patient.
The LR-PCR assay developed for the ampliﬁcation of the
entire genomic region of F8 described here (Fig. S1) effectively
identiﬁed the breakpoint in F8 intron 1. Recent advances in
LR-PCR techniques together with sequence information from
the HumanGenome Project, allows easy identiﬁcation of gross
rearrangements responsible for a number of genetic diseases.
Using this LR-PCR combined with sequence analysis
approach we have successfully analyzed this rearrangement
for the index patient without the need for laborious genomic
cloning procedures. In addition to the rearrangement presented
in this study, both previously characterized inversions (com-
prising introns 1 and 22) involve homologous recombination
events between two highly homologous inverted sequences.
Therefore, we believe that further characterization of other
severe cases of hemophilia A patients without detectable F8
mutations may reveal complex homologous recombination
events involving repetitive sequence hot spots. We suggest that
such a complex recombination mechanism might be the
fundamental cause of a number of severe hemophilia A cases
that, until now, have evaded speciﬁc genetic diagnosis.
In summary, we developed a working method for investi-
gating breakpoints and rearrangements in F8 that can serve as
a model for investigating any monogenetic disease phenotype
where no genetic basis can be found using traditional cDNA
sequencing methods. Using this approach, we characterized a
novel third inversion in F8 associated with severe hemophilia A
and we developed a speciﬁc short-range PCR analytical test
that is useful for both screening purposes as well as for carrier
detection and prenatal diagnosis.
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